Refine by
Insulin Dependent Suppliers & Manufacturers
10 companies found
based inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
We Have Reached Successful Pre-clinical results of our cell Therapy Treatment for Insulin-Dependent Diabetes. Diabetes mellitus is a chronic disorder characterized by high blood glucose levels and glucose ...
based inVista, CALIFORNIA (USA)
NOVO has been providing engineering services to medtech, biotech, print-tech, and other technical product companies for the last two decades. We are a company purpose built for developing new products and solving complex hardware and software ...
Device Types: On-body injectors; Autoinjectors; Pen injectors; Prefilled syringes; Insulin pumps; Microneedle array devices; Smart pills; Electroporation-enabled ...
based inActon, MASSACHUSETTS (USA)
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among ...
based inMainz, GERMANY
Fuelled by Innovation: With a pioneering spirit and high technical expertise, ORGENTEC has become firmly established in medical diagnostics. Our employees’ talent and skills establish the basis for our success. At our headquarters in Mainz, Germany, ...
Anti-Insulin is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against animal (beef, pork) and human insulin in human serum or plasma. Anti-Insulin is an ELISA test for the quantitative ...
based inCrumlin, UNITED KINGDOM
A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...
Diabetes is a life-long condition causing blood sugar levels to become too high and affects millions of people worldwide. Whilst the condition cannot be cured, it can be controlled and monitored. Randox diabetes reagents cover a spectrum of ...
based inMarburg, GERMANY
DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors. The German ...
The DRG C-Peptide ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of C-Peptide in serum, plasma (EDTA, lithium heparin or citrate plasma) and ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin ...
based inHsinchu, TAIWAN
EPS Bio Technology Corp. is a customer-oriented OEM/ODM manufacturer of glucose meter and strips with a vision of developing and marketing high quality diabetic self-monitoring blood glucose system (SMBG), as well as built on a solid history of ...
Visual reassurance with target range indicator provides simple feedback to help interpret blood glucose readings. The light of Neu Glucose Meter will illuminate according to your target range: high (above), green (within) and blue ...
based inSeocho-gu, SOUTH KOREA
Taking the first step in 1945, JW Group has found the market for domestic therapeutic drug based on its philosophy of respecting life and pioneering spirit. We are strengthening our global market competitiveness by developing leading health care ...
Active Ingredients: Mitiglinide calcium hydrate 10mg / Metformin HCl 500mg per 1 ...
based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit somatostatin, a pancreatic ...